Molecular Point-of-Care Diagnostics for Vector-Borne Pathogens: Biotechnological Innovations and Challenges in Field Implementation

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 26

فایل این مقاله در 26 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JADT-20-3_003

تاریخ نمایه سازی: 22 آبان 1405

چکیده مقاله:

Background: Centralized diagnostics can delay detection of vector-borne pathogens. Molecular point-of-care (mPOC) technologies may address this gap, but performance and field readiness remain uncertain.Methods: This rapid systematic review followed Cochrane Diagnostic Test Accuracy guidance. PubMed, Scopus and Web of Science (Clarivate) were searched for ۲۰۲۰–۲۰۲۵ publications (۱۳ September ۲۰۲۵). Two-by-two data were extracted or reconstructed, and sensitivity and specificity were recalculated with ۹۵% Wilson confidence in­ter­vals. Studies were classified by setting, assessed using the real-time connectivity, ease of specimen collection, afford­able, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliverable to end-users (REAS­SURED) criteria, and appraised with Quality Assessment of Diagnostic Accuracy Studies–۲. Heterogeneity led to narrative synthesis.Results: ۱,۹۶۴ records yielded ۲۲ studies: ۱۱ malaria, ۶ leishmaniasis and ۵ arboviral infections. Twenty-one stud­ies provided two-by-two data, yielding ۲۶ non-overlapping analyses. One study reported sensitivity only (۸۶.۴%, ۹۵% con­fidence interval ۷۵.۵–۹۳.۰%) and one analysis was not reconstructable. Median sample size was ۱۰۰ (in­terquartile range ۷۶.۵–۱۶۱.۵; range ۱۳–۴۹۰). Thirteen analyses reported ۱۰۰% sensitivity or specificity, but ۹ had lower confi­dence lim­its below ۹۰%. Four studies evaluated point-of-care tests. Based on lower confidence limits, ۸ met sensi­tivity and ۵ met specificity REASSURED thresholds; ۶ met real-time connectivity and ۷ met ease of spec­imen col­lection. Seventeen (۷۷.۳%) reported no cost data.Conclusions: mPOC technologies are promising, but evidence is dominated by laboratory or near-laboratory stud­ies with imprecise estimates. Multicenter field evaluations, standardized reporting including costs and complete two-by-two data are needed before integration.Background: Centralized diagnostics can delay detection of vector-borne pathogens. Molecular point-of-care (mPOC) technologies may address this gap, but performance and field readiness remain uncertain.Methods: This rapid systematic review followed Cochrane Diagnostic Test Accuracy guidance. PubMed, Scopus and Web of Science (Clarivate) were searched for ۲۰۲۰–۲۰۲۵ publications (۱۳ September ۲۰۲۵). Two-by-two data were extracted or reconstructed, and sensitivity and specificity were recalculated with ۹۵% Wilson confidence in­ter­vals. Studies were classified by setting, assessed using the real-time connectivity, ease of specimen collection, afford­able, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliverable to end-users (REAS­SURED) criteria, and appraised with Quality Assessment of Diagnostic Accuracy Studies–۲. Heterogeneity led to narrative synthesis.Results: ۱,۹۶۴ records yielded ۲۲ studies: ۱۱ malaria, ۶ leishmaniasis and ۵ arboviral infections. Twenty-one stud­ies provided two-by-two data, yielding ۲۶ non-overlapping analyses. One study reported sensitivity only (۸۶.۴%, ۹۵% con­fidence interval ۷۵.۵–۹۳.۰%) and one analysis was not reconstructable. Median sample size was ۱۰۰ (in­terquartile range ۷۶.۵–۱۶۱.۵; range ۱۳–۴۹۰). Thirteen analyses reported ۱۰۰% sensitivity or specificity, but ۹ had lower confi­dence lim­its below ۹۰%. Four studies evaluated point-of-care tests. Based on lower confidence limits, ۸ met sensi­tivity and ۵ met specificity REASSURED thresholds; ۶ met real-time connectivity and ۷ met ease of spec­imen col­lection. Seventeen (۷۷.۳%) reported no cost data.Conclusions: mPOC technologies are promising, but evidence is dominated by laboratory or near-laboratory stud­ies with imprecise estimates. Multicenter field evaluations, standardized reporting including costs and complete two-by-two data are needed before integration.

نویسندگان

Alireza Zare-Karizi

Department of Vector Biology and Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, Student’s Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

Bita Ghaderi

Department of Vector Biology and Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, Student’s Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Mehdi Sedaghat

Department of Vector Biology and Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Seyed Hojjat Khatamifar

Department of Medical Library and Information Science, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Javad Dehnavi

Department of Medical Library and Information Science, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

Baher Esmaeil-Pour

Department of Vector Biology and Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, Student’s Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran